中华心律失常学杂志
中華心律失常學雜誌
중화심률실상학잡지
CHINESE JOURNAL OF CARDIAC ARRHYTHMIAS
2014年
4期
269-274
,共6页
洪丽%刘金秋%王莹琦%潘晓杰%夏云龙%张树龙%高连君%杨延宗
洪麗%劉金鞦%王瑩琦%潘曉傑%夏雲龍%張樹龍%高連君%楊延宗
홍려%류금추%왕형기%반효걸%하운룡%장수룡%고련군%양연종
长QT13%基因型%表现型%QT间期%晕厥
長QT13%基因型%錶現型%QT間期%暈厥
장QT13%기인형%표현형%QT간기%훈궐
Long QT13%Genotype%Phenotype%QT interval%Syncope
目的 探讨长QT13 (LQT13)家系临床表现、心电学特点和基因型之间的关系.方法 研究入选了大连医科大学附属第一医院心内科1个LQT13家系,4代人,共有家族成员49例.家族调查包括临床病史、体格检查、心电图、超声心动图.采集44例血样,根据基因检测结果确定基因诊断.进一步采集基因诊断阳性的患者和匹配的健康对照者数字化心电图和动态心电图资料,比较两组心电参数的改变.结果 家系研究示7例临床诊断为先天性长QT综合征(LQTS).基因诊断9例阳性,包括7例临床确诊病例和2例疑似病例,女6例,男3例.基因突变为KIR3.4基因Gly387Arg突变.校正QT间期(QTc):440~490 (454±22) ms.女性患者QT间期偏长,好发晕厥,悲伤易诱发晕厥,有时在夜间发作.QT间期450~460ms的患者没有或者只有1次晕厥发生.该家系患者的晕厥首发均在20岁以后,在20~50岁期间晕厥发作频繁,50岁以后几乎不再发作.2例植入起搏器,β受体阻滞剂治疗有效.与健康对照组相比,LQT13患者QT间期延长主要表现在Q波与T波波峰间期(QTp)的延长.T波波峰到T波终点之间的间期(TpTe)没有改变.T波形状的评分(MCS)研究发现,与健康对照组相比T波起始部分的面积增加,T波幅度没有改变.24h动态心电图心率变异性分析发现,LQT13患者低频成份和高频成份比值(LF/HF)比正常对照组降低.结论 KIR3.4基因Gly387Arg突变引起LQT13.该LQT13家系女性患者多见,首发晕厥发生在成年以后,QT间期轻度延长,主要表现在T波起始部分的延长.临床结果相对良性,没有植入型心律转复除颤器(ICD),随访9年没有患者猝死.
目的 探討長QT13 (LQT13)傢繫臨床錶現、心電學特點和基因型之間的關繫.方法 研究入選瞭大連醫科大學附屬第一醫院心內科1箇LQT13傢繫,4代人,共有傢族成員49例.傢族調查包括臨床病史、體格檢查、心電圖、超聲心動圖.採集44例血樣,根據基因檢測結果確定基因診斷.進一步採集基因診斷暘性的患者和匹配的健康對照者數字化心電圖和動態心電圖資料,比較兩組心電參數的改變.結果 傢繫研究示7例臨床診斷為先天性長QT綜閤徵(LQTS).基因診斷9例暘性,包括7例臨床確診病例和2例疑似病例,女6例,男3例.基因突變為KIR3.4基因Gly387Arg突變.校正QT間期(QTc):440~490 (454±22) ms.女性患者QT間期偏長,好髮暈厥,悲傷易誘髮暈厥,有時在夜間髮作.QT間期450~460ms的患者沒有或者隻有1次暈厥髮生.該傢繫患者的暈厥首髮均在20歲以後,在20~50歲期間暈厥髮作頻繁,50歲以後幾乎不再髮作.2例植入起搏器,β受體阻滯劑治療有效.與健康對照組相比,LQT13患者QT間期延長主要錶現在Q波與T波波峰間期(QTp)的延長.T波波峰到T波終點之間的間期(TpTe)沒有改變.T波形狀的評分(MCS)研究髮現,與健康對照組相比T波起始部分的麵積增加,T波幅度沒有改變.24h動態心電圖心率變異性分析髮現,LQT13患者低頻成份和高頻成份比值(LF/HF)比正常對照組降低.結論 KIR3.4基因Gly387Arg突變引起LQT13.該LQT13傢繫女性患者多見,首髮暈厥髮生在成年以後,QT間期輕度延長,主要錶現在T波起始部分的延長.臨床結果相對良性,沒有植入型心律轉複除顫器(ICD),隨訪9年沒有患者猝死.
목적 탐토장QT13 (LQT13)가계림상표현、심전학특점화기인형지간적관계.방법 연구입선료대련의과대학부속제일의원심내과1개LQT13가계,4대인,공유가족성원49례.가족조사포괄림상병사、체격검사、심전도、초성심동도.채집44례혈양,근거기인검측결과학정기인진단.진일보채집기인진단양성적환자화필배적건강대조자수자화심전도화동태심전도자료,비교량조심전삼수적개변.결과 가계연구시7례림상진단위선천성장QT종합정(LQTS).기인진단9례양성,포괄7례림상학진병례화2례의사병례,녀6례,남3례.기인돌변위KIR3.4기인Gly387Arg돌변.교정QT간기(QTc):440~490 (454±22) ms.녀성환자QT간기편장,호발훈궐,비상역유발훈궐,유시재야간발작.QT간기450~460ms적환자몰유혹자지유1차훈궐발생.해가계환자적훈궐수발균재20세이후,재20~50세기간훈궐발작빈번,50세이후궤호불재발작.2례식입기박기,β수체조체제치료유효.여건강대조조상비,LQT13환자QT간기연장주요표현재Q파여T파파봉간기(QTp)적연장.T파파봉도T파종점지간적간기(TpTe)몰유개변.T파형상적평분(MCS)연구발현,여건강대조조상비T파기시부분적면적증가,T파폭도몰유개변.24h동태심전도심솔변이성분석발현,LQT13환자저빈성빈화고빈성빈비치(LF/HF)비정상대조조강저.결론 KIR3.4기인Gly387Arg돌변인기LQT13.해LQT13가계녀성환자다견,수발훈궐발생재성년이후,QT간기경도연장,주요표현재T파기시부분적연장.림상결과상대량성,몰유식입형심률전복제전기(ICD),수방9년몰유환자졸사.
Objective To investigate the relationship between the genotype and phenotype in LQT13.Methods A larger long QT syndrome(LQTS) family pedigree including 49 cases in four generations was evaluated.Clinical investigations,electrocardiograph (ECG),ultrasound cardiograph (UCG) were delivered to all family members.Blood samples were taken for the gene screen in 44 members.The digital ECG and dynamic ECG data were collected from LQT13 patients and matched healthy individuals compared.Results Seven cases were diagnosed as LQTS based on clinical evaluation.The KIR3.4-Gly387Arg mutation was found in 9 affected family members,including the 7 cases with positive clinical diagnosis and 2 suspected clinical cases,6 in female,and 3 male.The QT interval of female patients was relatively longer with frequent syncope.The syncope was easily induced by emotional stress.It may occur during night.Patients with shorter QT interval (450-460 ms) experienced only once or none syncope.The first syncope occurred after their twenties and occurred frequently from twenties to fifties.It seldom occurred after fifties.Pacemaker was implanted in 2 cases.β-blocker was effective in LQT13.Compared to healthy individuals,the mutation carriers were found to have prolonged QT peak interval with a significantly higher T-wave morphology combination score.Low frequency/high frequency ratio of heart rate variability was reduced in LQT13 patients.Conclusion The Kir3.4-Gly387Arg mutation leads to LQT13.Most of LQT13 patients are female.The first syncope attack occurs at their twenties.The QT interval is prolonged slightly with the first part of T wave prolongation.The prognosis of the LQT13 family members is relatively benign.No one experienced sudden cardiac death during the 9 years follow-up.